APA (7th ed.) Citation

Murai, K., Hikita, H., Yamada, R., Nishimura, Y., Miyazaki, M., Ishida, H., . . . Ogawa, H. (2025). The Risk of Developing Hepatocellular Carcinoma Persists in Chronic Hepatitis B Patients Even After the Long‐Term Administration of Nucleos(t)ide Analogs. Hepatology Research, 55(9), 1228. https://doi.org/10.1111/hepr.14225

Chicago Style (17th ed.) Citation

Murai, Kazuhiro, et al. "The Risk of Developing Hepatocellular Carcinoma Persists in Chronic Hepatitis B Patients Even After the Long‐Term Administration of Nucleos(t)ide Analogs." Hepatology Research 55, no. 9 (2025): 1228. https://doi.org/10.1111/hepr.14225.

MLA (9th ed.) Citation

Murai, Kazuhiro, et al. "The Risk of Developing Hepatocellular Carcinoma Persists in Chronic Hepatitis B Patients Even After the Long‐Term Administration of Nucleos(t)ide Analogs." Hepatology Research, vol. 55, no. 9, 2025, p. 1228, https://doi.org/10.1111/hepr.14225.